Understanding the Benefits of High Sensitivity Troponin for Clinicians

Presented by

Presenter: Lenette Walters

About this talk

For decades, cardiac troponin has been the preferred biomarker for helping to detect myocardial injury in acute care settings. The evolution of technology has led to the development of high sensitivity troponin assays that have greater precision at clinical decision points and enable lower limits of detection. This enhances clinicians’ ability to rule in or rule out acute myocardial infarction for timely intervention. Because of this, in 2018, “The Fourth Universal Definition of Myocardial Infarction” updated its guidelines to recommend the use of high sensitivity cardiac troponin assays that meet the precision criteria of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).1 Understanding the clinical utility and differences in high sensitivity cardiac troponin assays, compared to previous generation products, is vital to their implementation in the healthcare system. Cardiac troponin values , whole number reporting, the presence of acute ischaemia in patients presenting with chest pain, and sex-specific cutoffs all play a role in AMI diagnosis using high sensitivity troponin testing. This webinar explores these and other topics to provide an overview of the benefits of high sensitivity cardiac troponin assays. Better understanding of the capabilities and value of this technology can further its adopting and success in clinical practice.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (15)
Subscribers (22971)
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For more than 75 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes – offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation and information systems. Beckman Coulter is, and always has been, singularly devoted to moving science, innovation and the lab forward.